The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis

From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center, Amsterdam, the Netherlands. R. Agca, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; E.L. Kneepkens, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; C. van Dongen, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to Dr. M. Heslinga, Amsterdam Rheumatology and Immunology Center| Reade, Dr. Jan van Breemenstraat 2, 1056 AB, Amsterdam, the Netherlands. E-mail: m.heslinga@reade.nl. Accepted for publication March 22, 2017.

From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center, Amsterdam, the Netherlands. R. Agca, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; E.L. Kneepkens, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; C. van Dongen, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to Dr. M. Heslinga, Amsterdam Rheumatology and Immunology Center| Reade, Dr. Jan van Breemenstraat 2, 1056 AB, Amsterdam, the Netherlands. E-mail: m.heslinga@reade.nl. Accepted for publication March 22, 2017.

From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center, Amsterdam, the Netherlands. R. Agca, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; E.L. Kneepkens, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; C. van Dongen, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to Dr. M. Heslinga, Amsterdam Rheumatology and Immunology Center| Reade, Dr. Jan van Breemenstraat 2, 1056 AB, Amsterdam, the Netherlands. E-mail: m.heslinga@reade.nl. Accepted for publication March 22, 2017.

From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center, Amsterdam, the Netherlands. R. Agca, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; E.L. Kneepkens, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; C. van Dongen, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to Dr. M. Heslinga, Amsterdam Rheumatology and Immunology Center| Reade, Dr. Jan van Breemenstraat 2, 1056 AB, Amsterdam, the Netherlands. E-mail: m.heslinga@reade.nl. Accepted for publication March 22, 2017.

From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center, Amsterdam, the Netherlands. R. Agca, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; E.L. Kneepkens, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; C. van Dongen, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center| Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to Dr. M. Heslinga, Amsterdam Rheumatology and Immunology Center| Reade, Dr. Jan van Breemenstraat 2, 1056 AB, Amsterdam, the Netherlands. E-mail: m.heslinga@reade.nl. Accepted for publication March 22, 2017.